These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 16391537)
21. Benefit of vaginal sildenafil citrate in assisted reproduction therapy. Paulus WE; Strehler E; Zhang M; Jelinkova L; El-Danasouri I; Sterzik K Fertil Steril; 2002 Apr; 77(4):846-7. PubMed ID: 11937147 [No Abstract] [Full Text] [Related]
22. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction. Morales A J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738 [No Abstract] [Full Text] [Related]
23. What to do if Viagra won't do. Harv Mens Health Watch; 2005 May; 9(10):4-8. PubMed ID: 16044563 [No Abstract] [Full Text] [Related]
24. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Gregersen N; Jensen PT; Giraldi AE Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454 [TBL] [Abstract][Full Text] [Related]
25. Acute myocardial infarction associated with sildenafil. López-Lázaro L; García-Arenillas M; Portolés-Pérez A; Vargas-Castrillón E; Moreno-González A Lancet; 1998 Dec; 352(9144):1936-7. PubMed ID: 9863817 [No Abstract] [Full Text] [Related]
27. Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation? Méhats C; Schmitz T; Breuiller-Fouché M; Leroy MJ; Cabrol D Am J Obstet Gynecol; 2006 Jul; 195(1):184-5. PubMed ID: 16813753 [TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction. Dunn ME; Althof SE; Perelman MA Int J Impot Res; 2007; 19(2):119-23. PubMed ID: 16738695 [TBL] [Abstract][Full Text] [Related]
29. Novel therapeutic option in hypertensive crisis: sildenafil augments nitroprusside-induced hypotension. Bahadur MM; Aggarwal VD; Mali M; Thamba A Nephrol Dial Transplant; 2005 Jun; 20(6):1254-6. PubMed ID: 15784637 [No Abstract] [Full Text] [Related]
30. Optic atrophy after sildenafil use. Duszak R; Verghese M; Rinehart C; Alexander A Optometry; 2007 Jul; 78(7):329; author reply 329-30. PubMed ID: 17601569 [No Abstract] [Full Text] [Related]
31. Counseling patients about sexual issues. Stimmel GL; Gutierrez MA Pharmacotherapy; 2006 Nov; 26(11):1608-15. PubMed ID: 17064206 [TBL] [Abstract][Full Text] [Related]
32. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease. Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994 [TBL] [Abstract][Full Text] [Related]
33. [Sexuality in relation to heart disease. What effect does a dialogue between doctor and patient have?]. Berner MM Dtsch Med Wochenschr; 2002 Feb; 127(6):279-83. PubMed ID: 11832988 [No Abstract] [Full Text] [Related]
34. [Viagra vs a powerful Electuary?]. Nau JY Rev Med Suisse; 2007 Dec; 3(136):2812. PubMed ID: 18183820 [No Abstract] [Full Text] [Related]
35. Ophthalmic aspects of erectile dysfunction drugs. Verit A; Oguz H Am J Ophthalmol; 2006 Mar; 141(3):598; author reply 599. PubMed ID: 16490529 [No Abstract] [Full Text] [Related]
36. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. Raja SG; Danton MD; MacArthur KJ; Pollock JC J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298 [No Abstract] [Full Text] [Related]